FactCheckRadar Fact-check archive

Published fact-check

Heart inflammation risk: COVID-19 infection vs. vaccination

Supported

Claim checked

“Myocarditis after Covid vaccine 5 per million Myocarditis after Covid infection 150 per million”

Published

How it works

This report was created by FactCheckRadar chrome extension. Click here to get early access.

Verdict

Supported

The claim that myocarditis risk is significantly higher after a COVID-19 infection than after vaccination is supported by large-scale clinical data.

While the specific numbers cited (5 per million for vaccines and 150 per million for infection) vary slightly across different studies and demographics, the core assertion—that the risk from infection is many times higher than the risk from vaccination—is consistently backed by medical research. For example, a major study in England found the risk of myocarditis was at least 11 times higher following infection than after a first vaccine dose.

3 reviewed sources behind this verdict.

Reasoning

The evidence from multiple large-scale studies confirms that while myocarditis (inflammation of the heart muscle) is a rare side effect of COVID-19 mRNA vaccines, the risk of developing the same condition after a SARS-CoV-2 infection is substantially greater.

  • Comparative Risk: A systematic review and meta-analysis published in Frontiers in Cardiovascular Medicine (Source 2) found that the relative risk for myocarditis was more than seven times higher in the infection group compared to the vaccination group.
  • England Study Data: Research published in the American Heart Association journal Circulation (Source 1) analyzed data from 43 million people. It found that individuals infected with COVID-19 before vaccination were 11 times more at risk for myocarditis than those who had recently received a vaccine.
  • Incidence Rates: While the claim's specific figures (5 vs 150 per million) are simplified, they align with the general findings of these studies. Source 1 noted that out of 43 million vaccinated people, only 617 cases occurred within 28 days of a dose (approx. 14 per million), whereas the risk from infection was significantly higher, particularly in unvaccinated individuals.
  • Demographic Nuance: Both sources note that the risk of vaccine-associated myocarditis is highest in younger men (under 40), but even in these groups, the risk from the virus itself remains a serious concern. The studies conclude that the benefits of vaccination in preventing severe COVID-19 and its cardiac complications outweigh the small risk of vaccine-induced myocarditis.

Source quality: The verdict is based on a peer-reviewed meta-analysis of 22 studies (55.5 million people) and a massive population-level study from England's National Immunization database (43 million people).

Key checks

  • Relative risk of myocarditis: Studies show the risk of myocarditis is 7 to 11 times higher following a COVID-19 infection compared to vaccination.

  • Vaccine safety profile: While mRNA vaccines are associated with a small increase in myocarditis risk, particularly in young men, the overall incidence remains very low (approximately 0.007% in the general population).

Confidence

High

Was this useful?

Your vote helps us see which fact-checks deserve more attention.